Product information

From Health Canada

No match found

No other product was found from this company.

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Cancelled Pre Market

Current status date:

2018-08-07

Original market date: See footnote 1

Product name:

OFIRMEV

Description:

FOR I.V. INFUSION ONLY. 100ML SINGLE-USE VIALS

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02408066

Product Monograph/Veterinary Labelling:

Date: 2018-01-30 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

MALLINCKRODT HOSPITAL PRODUCTS INC.
440 Route 22 East
Bridgewater
New Jersey
United States 08807

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

28:08.92 

Anatomical Therapeutic Chemical (ATC): See footnote 4

N02BE01 ACETAMINOPHEN (PARACETAMOL)

Active ingredient group (AIG) number:See footnote5

0102009015

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
ACETAMINOPHEN 10 MG / ML
Version 4.0.3

"Page details"

Date modified: